Navigating The Privacy Tightrope For CTIS
Navigating The Privacy Tightrope For CTIS
Anonymizing personal data in clinical trials is essential for ethical compliance within the EU’s new CTIS framework. This process ensures patient privacy while enabling the responsible sharing of vast research datasets. For open data, it highlights the critical balance between transparency and privacy, demonstrating that rigorous de-identification is the foundation for trustworthy, scalable health data ecosystems.
Source: clinicalleader.comPublished on 2024-02-17
Related news
- Examining Supreme Court’s order on electoral bonds: Union minister Meghwal
- Seaton highlights costs of Augusta County supervisors FOIA lawsuit, attempts to stop appeal
- Public register
- Explained: Why the Supreme Court struck down the electoral bonds scheme
- CEOE CEPYME Cuenca asevera que los datos de sociedades mercantiles prueban las dificultades empresariales